Clinical outcome of Crohn's disease according to the Vienna classification: disease location is a useful predictor of disease course

被引:56
作者
Oostenbrug, Liekele E.
van Dullemen, Hendrik M.
te Meerman, Gerard J.
Jansen, Peter L. M.
Kleibeuker, Jan H.
机构
[1] Univ Groningen, Ctr Med, Dept Gastroenterol & Hepatol, NL-9700 RB Groningen, Netherlands
[2] Univ Groningen, Ctr Med, Dept Med Genet, NL-9700 RB Groningen, Netherlands
[3] Acad Med Ctr, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands
关键词
CARD15; Crohn's disease; genetic predisposition; NOD2; Vienna classification;
D O I
10.1097/00042737-200603000-00005
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objectives Crohn's disease (CD) is a complex genetic disease with multiple clinical patterns. Clinical classifications may help to identify subgroups of patients that have a distinct pattern of disease, and they are also a prerequisite for the conduction of genetic and therapeutic studies. The aim of this study was to determine the usefulness of the Vienna classification in patient care and clinical studies. Methods The clinical data of patients were carefully reviewed retrospectively. The behaviour and location of the disease were determined according to the Vienna classification and additional clinical characteristics including surgical data, vitamin 1312 status and medication were also assessed. Results Data according to the Vienna classification of 292 CD cases were available. The mean age at diagnosis was 31.4 years. The operation rate was higher in patients with ileocolonic localization (P < 0.05) and stricturing and penetrating disease behaviour (P < 0.001). The incidence of vitamin B12 deficiency was 41.9% in cases with ileal involvement and 20.7% in cases with disease confined to the colon. In 187 cases (64.0%) an operation was performed because of CD-related complications, in a majority (126, 674%) this took place within 5 years after diagnosis. Intolerance of azathioprine occurred in 36 cases (22.0%). Conclusions IIeocolonic disease localization is associated with a complicated course of disease. Vitamin B12 deficiency occurs frequently, also in patients with disease apparently confined to the colon. We propose that location parameters can be used for the prediction of disease course in clinical settings and in interventional studies. Eur J Gastroenterol Hepatol 18:255-261 (c) 2006 Lippincott Williams & Wilkins.
引用
收藏
页码:255 / 261
页数:7
相关论文
共 27 条
[1]
DIRECT AND QUANTITATIVE VITAMIN-B12 ABSORPTION MEASUREMENT IN PATIENTS WITH DISORDERS IN THE DISTAL PART OF THE BOWEL - COMPARISON OF THE STOOL SPOT-TEST [SST] WITH WHOLE-BODY COUNTING IN PATIENTS WITH ILEAL PELVIC RESERVOIR, ILEOSTOMY OR CROHNS-DISEASE [J].
BAYAT, M ;
BRYNSKOV, J ;
DIGEPETERSEN, H ;
HIPPE, E ;
LONBORGJENSEN, H .
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 1994, 9 (02) :68-72
[2]
Defining complex contributions of NOD2/CARD15 gene mutations, age at onset, and tobacco use on Crohn's disease phenotypes [J].
Brant, SR ;
Picco, MF ;
Achkar, JP ;
Bayless, TM ;
Kane, SV ;
Brzezinski, A ;
Nouvet, FJ ;
Bonen, D ;
Karban, A ;
Dassopoulos, T ;
Karaliukas, R ;
Beaty, TH ;
Hanauer, SB ;
Duerr, RH ;
Cho, JH .
INFLAMMATORY BOWEL DISEASES, 2003, 9 (05) :281-289
[3]
EPIDEMIOLOGY OF INFLAMMATORY BOWEL-DISEASE [J].
CALKINS, BM ;
MENDELOFF, AI .
EPIDEMIOLOGIC REVIEWS, 1986, 8 :60-91
[4]
Prevalence of undiagnosed pernicious anemia in the elderly [J].
Carmel, R .
ARCHIVES OF INTERNAL MEDICINE, 1996, 156 (10) :1097-1100
[5]
Transmission of CARD15 (NOD2) variants within families of patients with inflammatory bowel disease [J].
Esters, N ;
Pierik, M ;
van Steen, K ;
Vermeire, S ;
Claessens, G ;
Joossens, S ;
Vlietinck, R ;
Rutgeerts, P .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (02) :299-305
[6]
Application of the Vienna Classification for Crohn's disease to a single clinician database of 877 patients [J].
Freeman, HJ .
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2001, 15 (02) :89-93
[7]
A simple classification of Crohn's disease: Report of the Working Party for the world congresses of gastroenterology, Vienna 1998 [J].
Gasche, C ;
Scholmerich, J ;
Brynskov, J ;
D'Haens, G ;
Hanauer, SB ;
Irvine, EJ ;
Jewell, DP ;
Rachmilewitz, D ;
Sachar, DB ;
Sandborn, WJ ;
Sutherland, LR .
INFLAMMATORY BOWEL DISEASES, 2000, 6 (01) :8-15
[8]
CARD15/NOD2 gene variants are associated with familially occurring and complicated forms of Crohn's disease [J].
Hehliö, T ;
Halme, L ;
Lappalainen, M ;
Fodstad, H ;
Paavola-Sakki, P ;
Turunen, U ;
Färkkilä, M ;
Krusius, T ;
Kontula, K .
GUT, 2003, 52 (04) :558-562
[9]
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease [J].
Hugot, JP ;
Chamaillard, M ;
Zouali, H ;
Lesage, S ;
Cézard, JP ;
Belaiche, J ;
Almer, S ;
Tysk, C ;
O'Morain, CA ;
Gassull, M ;
Binder, V ;
Finkel, Y ;
Cortot, A ;
Modigliani, R ;
Laurent-Puig, P ;
Gower-Rousseau, C ;
Macry, J ;
Colombel, JF ;
Sahbatou, M ;
Thomas, G .
NATURE, 2001, 411 (6837) :599-603
[10]
Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease [J].
Kirschner, BS .
GASTROENTEROLOGY, 1998, 115 (04) :813-821